Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP9 | P14780 | 9/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
| ▸ | MMP2 | P08253 | 9/20 | 0.59 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.59 |
| ▸ | CTSL | P07711 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | ADAMTS5 | Q9UNA0 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | CA2 | P00918 | 1/20 | 0.55 |
| ▸ | CA7 | P43166 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | MMP1 | P03956 | 1/20 | 0.53 |
| ▸ | MMP3 | P08254 | 1/20 | 0.53 |
| ▸ | MMP7 | P09237 | 1/20 | 0.53 |
| ▸ | MMP13 | P45452 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5481551 | 1.00 | MMP9 (0.60) | MMP9TDP1MMP2ADAMTS4CTSL | |
| SCHEMBL8018411 | 0.91 | MMP9 (0.61) | MMP9TDP1MMP2ADAMTS4CTSL | |
| SCHEMBL14519991 | 0.87 | MMP9 (0.63) | MMP9TDP1MMP2ADAMTS4CTSL | |
| SCHEMBL15213296 | 0.87 | MMP9 (0.63) | MMP9TDP1MMP2ADAMTS4CTSL | |
| SCHEMBL4948256 | 0.87 | MMP9 (0.57) | MMP9TDP1MMP2ADAMTS4CTSL | |
| SCHEMBL2926667 | 0.87 | MMP9 (0.57) | MMP9TDP1MMP2ADAMTS4CTSL | |
| Chloromethane SCHEMBL7649372 | 0.86 | MMP2 (0.75) | MMP9TDP1MMP2ADAMTS4CTSL | |
| SCHEMBL628639 | 0.86 | MMP9 (0.64) | MMP9TDP1MMP2ADAMTS4CTSL | |
| SCHEMBL20601786 | 0.86 | MMP9 (0.64) | MMP9TDP1MMP2ADAMTS4CTSL | |
| SCHEMBL628640 | 0.86 | MMP9 (0.64) | MMP9TDP1MMP2ADAMTS4CTSL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-11228352-A | — | — | None | — | — | JP | disclosed |
| EP-4000905-B1 | PUNCTURE SEALANT | SUMITOMO RUBBER IND (JP) | 2025-04-09 | — | — | EP | disclosed |
| WO-2024151802-A2 | METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING ITCH | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2024-07-18 | — | — | WO | disclosed |
| CN-118272323-A | Influenza B virus mutants and uses thereof | 复尔健有限公司 | 2024-07-02 | — | — | CN | disclosed |
| CN-117693359-A | Broadly reactive viral antigens as immunogens, compositions and methods of use | 乔治亚大学研究基金会股份有限公司 | 2024-03-12 | — | — | CN | disclosed |
| CN-117561449-A | Biomarkers for determining immune oncologic response | 维恩生物科学公司 | 2024-02-13 | — | — | CN | disclosed |
| CN-110573613-B | Influenza B virus mutants and uses thereof | 复尔健有限公司 | 2024-01-09 | — | — | CN | disclosed |
| US-11732113-B2 | Puncture sealant | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2023-08-22 | — | — | US | disclosed |
| CN-116456895-A | Biomarkers for diagnosing non-alcoholic steatohepatitis (NASH) or hepatocellular carcinoma (HCC) | 韦恩生物科技股份公司 | 2023-07-18 | — | — | CN | disclosed |
| EP-4000905-A1 | PUNCTURE SEALANT | Sumitomo Rubber Industries, Ltd. (JP) | 2022-05-25 | — | — | EP | disclosed |
| EP-0434605-B1 | Novel process for the production of unfused protein in E. coli | CIBA GEIGY AG (CH) | 1996-09-11 | — | — | EP | disclosed |
| WO-1995035366-A1 | ANIMAL MODEL FOR ALZHEIMER'S DISEASE | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 1995-12-28 | — | — | WO | disclosed |
| EP-0537155-A1 | PURIFIED RAP GAPs, RAP GAP SEQUENCES, AND USES THEREOF | CHIRON CORPORATION (US) | 1993-04-21 | — | — | EP | disclosed |
| WO-1993000926-A1 | TREATMENT OF PERIODONTAL DISEASE WITH PROTEASE INHIBITORS | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 1993-01-21 | — | — | WO | disclosed |
| WO-1991015582-A2 | PURIFIED RAP GAPs, RAP GAP SEQUENCES, AND USES THEREOF | CETUS CORPORATION (US) | 1991-10-17 | — | — | WO | disclosed |
| EP-0434605-A2 | Novel process for the production of unfused protein in E. coli | CIBA-GEIGY AG (CH) | 1991-06-26 | — | — | EP | disclosed |
| US-4906571-A | Cell surface modification using a novel glycoproteinase of pasteurella haemolytica | UNIVERSITY OF GUELPH (CA) | 1990-03-06 | — | — | US | disclosed |
| US-4861865-A | Novel antithrombin peptide | WASHINGTON UNIVERSITY (US) | 1989-08-29 | — | — | US | disclosed |
| EP-0182906-A1 | HUMAN LEUKOCYTE ELASTASE INHIBITORS PREPARED FROM PYOGENIC BACTERIA AND METHODS FOR THEIR PURIFICATION | CORTECH, INC. (US) | 1986-06-04 | — | — | EP | disclosed |
| WO-1986000077-A1 | HUMAN LEUKOCYTE ELASTASE INHIBITORS PREPARED FROM PYOGENIC BACTERIA AND METHODS FOR THEIR PURIFICATION | CORTECH, INC. (US) | 1986-01-03 | — | — | WO | disclosed |